Sevan Habeshian
Platform Chemistry Co-Founder & Vice President Orbis Medicines
Sevan Habeshian is an entrepreneurial chemist and drug discovery innovator with extensive experience developing novel technologies and platforms for therapeutic discovery. As Co-Founder and Chief Technology Officer, he leads multidisciplinary research teams focused on advancing next-generation macrocyclic therapeutics and overcoming some of the most challenging targets in drug development.
Throughout his career, Sevan has combined expertise in medicinal chemistry, platform development, and strategic scientific leadership to accelerate the discovery of innovative drug candidates. He has played a key role in designing and implementing cutting-edge drug discovery approaches, building high-performing research organizations, and translating scientific concepts into impactful therapeutic opportunities.
Passionate about pushing the boundaries of modern drug discovery, Sevan continues to drive innovation at the intersection of chemistry and biology, helping to unlock the potential of macrocycles as a powerful modality for the treatment of complex diseases.
Seminars
- Explore innovative peptide synthesis and cyclisation strategies to generate structurally diverse libraries with enhanced stability, potency and drug-like properties.
- Compare next-generation screening platforms, including DNA-Encoded Libraries (DEL) and Affinity Selection Mass Spectrometry (ASMS), to identify high-quality peptide hits beyond traditional display technologies.
- Discover how integrated synthesis and screening workflows can improve hit quality, shorten discovery timelines and accelerate progression towards clinically relevant peptide candidates.
